Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04674683
Title Study Comparing Investigational Drug HBI-8000 Combined With Nivolumab vs. Nivolumab in Patients With Advanced Melanoma
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors HUYABIO International, LLC.
Indications

melanoma

Therapies

Nivolumab

Chidamide + Nivolumab

Age Groups: child | adult | senior
Covered Countries USA | FRA | ESP | DEU | BEL


No variant requirements are available.